Security key
45781K204
- Security type / class
- Equity / SPONSORED ADS
- Total 13F shares
- 234,858
- Total 13F value
- $734,353
- Share change
- -161,683
- SEC-reported price per share
- $3.14
- Number of holders
- 8
- Value change
- -$489,953
- Number of buys
- 3
- Number of sells
- 6
Report period
Q2 2023
Institutions
8
Top holders
9
IPHA full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q3 2025
Innate Pharma SA SEC filings
Innate Pharma SA company facts
Broader feeds
Reporting periods
Holder history for CUSIP 45781K204
Recent filing periods:
Ownership snapshot
Top reported holders of IPHA - Innate Pharma SA - SPONSORED ADS (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
Optiver Holding B.V.
Disclosed value leader
Optiver Holding B.V.
Comparable rows
0/8
Latest evidence
31 Mar 2023
13F
Highest disclosed value: $636,435
8 rows are not safely comparable across share classes.
Showing 1-6 of 8 holder rows.
Quick read
Optiver Holding B.V. has the largest disclosed position value at $636.4K.
0 of 8 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens Optiver Holding B.V.'s linked filing trail.
Disclosed position value
Top 5
Optiver Holding B.V.
$636.4K
MILLENNIUM MANAGEMENT LLC
$176K
MORGAN STANLEY
$138.9K
BANK OF AMERICA CORP /DE/
$133.2K
SUSQUEHANNA INTERNATIONAL GROUP, LLP
$37.8K
Value bars compare disclosed positions; verify each figure against the linked filing evidence.
Detailed SEC evidence table Showing 1-6 of 8 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| Optiver Holding B.V. |
13F
Company
|
—
denominator unverified
|
$636,435
224,097 shares
|
— | 31 Mar 2023 |
| MILLENNIUM MANAGEMENT LLC |
13F
Company
|
—
denominator unverified
|
$176,000
61,899 shares
|
— | 31 Mar 2023 |
| MORGAN STANLEY |
13F
Company
|
—
denominator unverified
|
$138,858
48,722 shares
|
— | 31 Mar 2023 |
| BANK OF AMERICA CORP /DE/ |
13F
Company
|
—
denominator unverified
|
$133,235
46,749 shares
|
— | 31 Mar 2023 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP |
13F
Company
|
—
denominator unverified
|
$37,815
13,315 shares
|
— | 31 Mar 2023 |
| UBS Group AG |
13F
Company
|
—
denominator unverified
|
$3,588
1,259 shares
|
— | 31 Mar 2023 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q2 2023
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
8
Shares
234,858
Rows available
8
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q2 2023 vs Q2 2026 Across Filers
Q2 2026 holders
10
Q2 2023 holders
8
Holder diff
-2
| Investor | Q2 2026 Shares | Q2 2023 Shares | Share Diff | Share Chg % | Q2 2026 value | Q2 2023 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend